September 10, 2020
4G Clinical
May 29, 2020
5 Supply Chain Impacts Resulting from Master Protocol Amendments – And How to Prepare
4G Clinical
March 23, 2020
The Site Perspective: COVID-19 and the movement towards Direct-to-Patient trials
4G Clinical
Scenario planning is not just comparing two detailed data sets. To be meaningful, it must explore possible outcomes based on a specific combination of events while balancing risks and costs. With so many variables, how do you inform the best strategy? Here is our ultimate guide to scenario planning clinical supply decisions.
October 10, 2019
Power of Excel & The Case for Moving Beyond the Beloved Tool for Clinical Trial Forecasting
4G Clinical
August 7, 2019
Site Voice #2 | If you could influence RTSM/clinical systems design, what would you change?
4G Clinical
July 31, 2019
Top 5 Questions to Ask When Considering RTSM Systems for Phase 1 Clinical Trials
4G Clinical
July 17, 2019
Top 6 Benefits of Leveraging an RTSM for Investigator Initiated Trials (IITs)
4G Clinical
July 10, 2019
Clinical Trial Myth #4: If You Try To Get Into Clinical Research, You Will Not Be Eligible
4G Clinical
On Wednesday, June 26th, 4G Clinical co-founders David Kelleher and Ed Tourtellotte were recognized as finalists for EY’s Entrepreneur Of The Year ®2019 Award for the New England region. An impressive group of unstoppable entrepreneurs from 36 companies across many industries celebrated entrepreneurship throughout the evening at the Westin Waterfront hotel in Boston.
June 12, 2019
Clinical Trial Myth #2 - If You Take Part In Clinical Research, You Will Not Be Helped
4G Clinical
May 17, 2019
4G Clinical Supports CISCRP's Debunking Common Myths Campaign through an Educational Video Series
4G Clinical
August 22, 2017
How Natural Language Processing (NLP) is a Game Changer in Clinical Research
4G Clinical